History and current trends in the treatment of idiopathic overactive bladder
Language English Country Czech Republic Media print
Document type Journal Article, Review
PubMed
34493055
DOI
10.48095/cccg2021284
PII: 127965
Knihovny.cz E-resources
- Keywords
- anticholinergics, botulinum toxin A, electrostimulation, mirabegron, overactive bladder, urgency,
- MeSH
- Muscarinic Antagonists therapeutic use MeSH
- Benzhydryl Compounds MeSH
- Urinary Bladder, Overactive * therapy MeSH
- Quality of Life MeSH
- Humans MeSH
- Solifenacin Succinate MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Muscarinic Antagonists MeSH
- Benzhydryl Compounds MeSH
- Solifenacin Succinate MeSH
OBJECTIVE: Historical and current view on the therapy of overactive bladder. METHODS: This review summarizes the historical approach and current therapy of overactive bladder. The articles were gathered from Pubmed and Scopus databases. Studies published before December 2020 were used for the review. RESULTS AND CONCLUSION: Overactive bladder is a condition that quite a lot reduces the quality of life of our patients. Our therapeutic approach starts with non-pharmacological treatment, such as pelvic floor exercises. The next step is a pharmacological approach. The entry level drug is trospium. If the effect is not sufficient, propiverine, solifenacin, fesoterodine, darifenacin or mirabegron are used. Electrostimulation or botulinum toxin A application is an option only in cases that didnt respond to pharmacological treatment. It is safe to say, that in the end, there is a way of reducing the severity of overactive bladder symptoms for every patient.
References provided by Crossref.org